Perioperative Antithrombotics in Vitreoretinal Surgery

Retinal surgeons can enhance their knowledge to effectively collaborate with a patient’s care team.

By Kamal Kishore, MD, FASRS

Intravitreal Methotrexate for the Treatment and Prevention of Proliferative Vitreoretinopathy

Forthcoming trial results could help clarify the role.

By Priya Vakharia, MD

Etiology and Diagnosis of Vision Degrading Myodesopsia

Part 1 of a 3-part series on a vitreous pathology that can profoundly impact patients’ lives.

By Wei Gui, MD, Ronald H. Silverman, PhD, J. Sebag, MD

Updates to and Current Techniques for 27-gauge Vitrectomy

Technological evolution has facilitated more widespread use.

By Taku Wakabayashi, MD, PhD, Yoshihiro Yonekawa, MD, Yusuke Oshima, MD, PhD

Immersive Visualization With Heads-up Surgery

New iterations build on previous successes.

By Jorge A. Fortun, MD

2022 ASRS Retina Product Pavilion

Interpreting Pertinent OCT Signs

An understanding of nuances can enhance decision-making and improve outcomes.

By Steven Bloom, MD, Janelle Fassbender Adeniran, MD

UPFRONT: Bring ARVO Back to Its Roots

By Peter K. Kaiser, MD

CODING Q&A: Auditing Medical Records

With federal agencies stepping up investigations, it’s imperative that you establish a first line of defense.

By Suzanne L. Corcoran, COE

NEW PRODUCT APPLICATIONS: Xipere Suprachoroidal Injection for Uveitis

Novel back-of-the-eye treatment boosts BCVA.

By ANDREA BONNER, CONTRIBUTING EDITOR

Clinical Trial Update June 2022

SUBSPECIALTY NEWS: Geographic atrophy quality-of-life survey, Xipere launch, ophthalmic bevacizumab FDA application, and more.

By Rochelle Nataloni, contributing writer